INNATE PHARMA EUR0.05 earnings per share and revenue

0EVI earnings per share for the last semiannual are -0.12 EUR whereas the estimation was -0.40 EUR which accounts for 70.25% surprise. Company revenue for the same period amounts to 21.42 M EUR despite the estimated figure of 16.82 M EUR. Estimated earnings per share for the next semiannual are -0.35 EUR, and revenue is expected to reach 8.27 M EUR. Also watch annual changes over time to get a bigger picture of 0EVI earnings per share and revenue dynamics.